The soluble VEGFR1 concentration in the serum of patients with colorectal cancer

被引：0
|
作者：
Oranus Abbasi
Farhad Mashayekhi
Ebrahim Mirzajani
Saba Fakhriyeh Asl
Touraj Mahmoudi
Hamid Saeedi Saedi
机构：
[1] University of Guilan,Department of Cell and Molecular Biology, Pardis International
[2] University of Guilan,Department of Biology, Faculty of Sciences
[3] Guilan University of Medical Sciences,Cellular and Molecular Research Center, Faculty of Medicine
[4] Guilan University of Medical Science,Division of Gastroenterology and Liver Disease, Gastric and Liver Disease Research Center
[5] Shahid Beheshti University of Medical Sciences,Gastroenterology and Liver Diseases Research Center
[6] Guilan University of Medical Sciences,Razi Hospital
来源：
Surgery Today | 2015年 / 45卷
关键词：
Soluble VEGFR1; Colorectal cancer; Ectodomain shedding; Serum;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 220
页数：5
相关论文
共 50 条
  • [1] The soluble VEGFR1 concentration in the serum of patients with colorectal cancer
    Abbasi, Oranus
    Mashayekhi, Farhad
    Mirzajani, Ebrahim
    Asl, Saba Fakhriyeh
    Mahmoudi, Touraj
    Saedi, Hamid Saeedi
    SURGERY TODAY, 2015, 45 (02) : 215 - 220
  • [2] K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRα in colorectal cancer
    Schimanski, Carl C.
    Zimmermann, Tim
    Schmidtmann, Irene
    Gockel, Ines
    Lang, Hauke
    Galle, Peter R.
    Moehler, Markus
    Berger, Martin R.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (02) : 181 - 186
  • [3] Changes in serum soluble VEGFR-1 and Tie-2 receptors in colorectal cancer patients following surgical resections
    Chin, KF
    Greenman, J
    Reusch, P
    Gardiner, E
    Marme, D
    Monson, J
    ANTICANCER RESEARCH, 2004, 24 (04) : 2353 - 2357
  • [4] K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRα in colorectal cancer
    Carl C. Schimanski
    Tim Zimmermann
    Irene Schmidtmann
    Ines Gockel
    Hauke Lang
    Peter R. Galle
    Markus Moehler
    Martin R. Berger
    International Journal of Colorectal Disease, 2010, 25 : 181 - 186
  • [5] IS SOLUBLE VEGFR1 A PUTATIVE BIOMARKER AND THERAPEUTIC TARGET FOR BPS/IC?
    Ribeiro-Oliveira, R.
    Mendes, P.
    Manso, M.
    Pinto, R.
    Cruz, F.
    Charrua, A.
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S271 - S272
  • [6] Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma
    Al-Maghrabi, Jaudah
    Gomaa, Wafaey
    Buhmeida, Abdelbaset
    Qari, Yousif
    Al-Qahtani, Mohammad
    Al-Ahwal, Mahmoud
    TUMOR BIOLOGY, 2014, 35 (09) : 9045 - 9051
  • [7] Serum zinc concentration in patients with colorectal cancer
    Zowczak-Drabarczyk, M
    Torlinska, T
    Iskra, M
    Mielcarz, G
    Matylla, G
    Torlinski, L
    TRACE ELEMENTS AND ELECTROLYTES, 2004, 21 (04) : 236 - 239
  • [8] SOLUBLE FORM OF VEGFR1 AS A PUTATIVE BIOMARKER AND THERAPEUTIC TARGET FOR BPS/IC
    Ribeiro-Oliveira, Rita
    Mendes, Pedro
    Manso, Margarida
    Pinto, Rui
    Cruz, Francisco
    Charrua, Ana
    JOURNAL OF UROLOGY, 2020, 203 : E99 - E100
  • [9] VEGF, VEGFR1 and microvessel density in papillary thyroid cancer
    Ivanova, K.
    Ananiev, J.
    Onal, E.
    Vlaykova, T.
    Gulubova, M.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 150 - 150
  • [10] Soluble VEGFR1 signaling guides vascular patterns into dense branching morphologies
    Lakatos, Dora
    Somfai, Ellak
    Mehes, Elod
    Czirok, Andras
    JOURNAL OF THEORETICAL BIOLOGY, 2018, 456 : 261 - 278
12345